Kisla Ekinci, R. M., Balci, S., Hershfield, M., Bisgin, A., Dogruel, D., Altintas, D. U., & Yilmaz, M. (2020). Deficiency of adenosine deaminase 2: a case series revealing clinical manifestations, genotypes and treatment outcomes from Turkey. Rheumatology (Oxford), 59(1), 254–256. https://doi.org/10.1093/rheumatology/kez260

Kisla Ekinci, Rabia Miray, Sibel Balci, Michael Hershfield, Atil Bisgin, Dilek Dogruel, Derya Ufuk Altintas, and Mustafa Yilmaz. “Deficiency of adenosine deaminase 2: a case series revealing clinical manifestations, genotypes and treatment outcomes from Turkey.” Rheumatology (Oxford) 59, no. 1 (January 1, 2020): 254–56. https://doi.org/10.1093/rheumatology/kez260.

Kisla Ekinci RM, Balci S, Hershfield M, Bisgin A, Dogruel D, Altintas DU, et al. Deficiency of adenosine deaminase 2: a case series revealing clinical manifestations, genotypes and treatment outcomes from Turkey. Rheumatology (Oxford). 2020 Jan 1;59(1):254–6.

Kisla Ekinci, Rabia Miray, et al. “Deficiency of adenosine deaminase 2: a case series revealing clinical manifestations, genotypes and treatment outcomes from Turkey.” Rheumatology (Oxford), vol. 59, no. 1, Jan. 2020, pp. 254–56. Pubmed, doi:10.1093/rheumatology/kez260.

Kisla Ekinci RM, Balci S, Hershfield M, Bisgin A, Dogruel D, Altintas DU, Yilmaz M. Deficiency of adenosine deaminase 2: a case series revealing clinical manifestations, genotypes and treatment outcomes from Turkey. Rheumatology (Oxford). 2020 Jan 1;59(1):254–256.